Roche said it would increase its dividend after its hemophilia injection Hemlibra and multiple sclerosis treatment Ocrevus lifted sales in the first nine months of the year.
Related Posts
U.S. Steelmakers Warn of Lower Profits as Manufacturers Slow Factories
Nucor and Steel Dynamics forecast a drop in third-quarter earnings, citing weaker demand and shaky prices.
Vivendi Chooses London and Amsterdam for Possible Unit Listings
Vivendi said it would list its core television and advertising businesses in London and Amsterdam as the conglomerate looks cash in on investment opportunities outside […]
Novo Nordisk’s Wegovy Weight-Loss Drug Gets Approval in China
Blockbuster obesity drug Wegovy has been approved in China, opening the door for maker Novo Nordisk to begin selling it in the world’s second-largest economy, […]